title: A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans.
abstract: TAC1, a Candida albicans transcription factor situated near the mating-type locus on chromosome 5, is necessary for the upregulation of the ABC-transporter genes CDR1 and CDR2, which mediate azole resistance. We showed previously the existence of both wild-type and hyperactive TAC1 alleles. Wild-type alleles mediate upregulation of CDR1 and CDR2 upon exposure to inducers such as fluphenazine, while hyperactive alleles result in constitutive high expression of CDR1 and CDR2. Here we recovered TAC1 alleles from two pairs of matched azole-susceptible (DSY294; FH1: heterozygous at mating-type locus) and azole-resistant isolates (DSY296; FH3: homozygous at mating-type locus). Two different TAC1 wild-type alleles were recovered from DSY294 (TAC1-3 and TAC1-4) while a single hyperactive allele (TAC1-5) was isolated from DSY296. A single amino acid (aa) difference between TAC1-4 and TAC1-5 (Asn977 to Asp or N977D) was observed in a region corresponding to the predicted activation domain of Tac1p. Two TAC1 alleles were recovered from FH1 (TAC1-6 and TAC1-7) and a single hyperactive allele (TAC1-7) was recovered from FH3. The N977D change was seen in TAC1-7 in addition to several other aa differences. The importance of N977D in conferring hyperactivity to TAC1 was confirmed by site-directed mutagenesis. Both hyperactive alleles TAC1-5 and TAC1-7 were codominant with wild-type alleles and conferred hyperactive phenotypes only when homozygous. The mechanisms by which hyperactive alleles become homozygous was addressed by comparative genome hybridization and single nucleotide polymorphism arrays and indicated that loss of TAC1 heterozygosity can occur by recombination between portions of chromosome 5 or by chromosome 5 duplication.
authors.affiliation: Institute of Microbiology, University Hospital Lausanne, Switzerland.
authors.forename: Alix
authors.initials: A
authors.lastname: Coste
authors.forename: Vincent
authors.initials: V
authors.lastname: Turner
authors.forename: Françoise
authors.initials: F
authors.lastname: Ischer
authors.forename: Joachim
authors.initials: J
authors.lastname: Morschhäuser
authors.forename: Anja
authors.initials: A
authors.lastname: Forche
authors.forename: Anna
authors.initials: A
authors.lastname: Selmecki
authors.forename: Judith
authors.initials: J
authors.lastname: Berman
authors.forename: Jacques
authors.initials: J
authors.lastname: Bille
authors.forename: Dominique
authors.initials: D
authors.lastname: Sanglard
mesh_terms: D018528:ATP-Binding Cassette Transporters / Q000235:genetics*; D000483:Alleles; D000935:Antifungal Agents / Q000494:pharmacology*; D002176:Candida albicans / Q000235:genetics*; D015825:Chromosomes, Fungal; D004352:Drug Resistance, Microbial; D005476:Fluphenazine / Q000494:pharmacology; D005656:Fungal Proteins / Q000235:genetics*; D006579:Heterozygote; D006720:Homozygote; D019656:Loss of Heterozygosity; D026901:Membrane Transport Proteins / Q000235:genetics*; D009693:Nucleic Acid Hybridization; D020641:Polymorphism, Single Nucleotide; D014157:Transcription Factors / Q000737:chemistry / Q000235:genetics* / Q000502:physiology
chemical_list: D018528:ATP-Binding Cassette Transporters; D000935:Antifungal Agents; C094693:CDR1 protein, Candida albicans; D005656:Fungal Proteins; D026901:Membrane Transport Proteins; D014157:Transcription Factors; D005476:Fluphenazine